Is there a clinically significant increased risk of venous thromboembolism with the use of fulvestrant for metastatic HR+ breast cancer?
In a patient with a history of VTE (now off anticoagulants), is it safe to administer fulvestrant?
Answer from: Medical Oncologist at Academic Institution
The reason for VTE? Post-operative, trauma, hypercoagulability due to having cancer or its treatment, hereditary hypercoagulability, or idiopathic? I am going to assume that the VTE was self-limited and treated with a course of anticoagulation. Does fulvestrant cause VTE? Ideally, a randomized place...
Sign in or Register to read more